Drug profile · INN
abaloparatide
ELADYNOS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
abaloparatide (ELADYNOS) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN abaloparatide
Brand ELADYNOS
Route SUBCUTANEOUS
Formulation SOLUTION
ATC code H05AA04
Frequently asked questions
What is abaloparatide?
abaloparatide (ELADYNOS) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for abaloparatide?
ELADYNOS is a marketed brand name for abaloparatide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of abaloparatide?
abaloparatide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.